Endoscope Reprocessing Market worth 2.15 Billion USD by 2022

By -

Endoscope reprocessing caters to a diverse group of end users, namely, hospitals, ambulatory surgery centers, and other end users such as diagnostic centers, mobile endoscopy facilities, and office endoscopy centers.

(EMAILWIRE.COM, October 22, 2019 ) The Global Endoscope Reprocessing Market is expected to reach the US $2.15 billion, at a CAGR of 8.6%

Factors such as high risk of infections associated with improper sterilization of endoscopes, increasing investments, funds, and grants by government bodies across the globe, rising number of hospitals and growing hospital investments in endoscopy instruments, and rising prevalence of diseases that require endoscopy procedures are driving the growth of the endoscope reprocessing market during the forecast period.


Download PDF (Endoscope Reprocessing): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219094994

Endoscope Reprocessing Market segmentation:

• based on products
• based on end users
• based on regions.

Advanced Sterilization Products (ASP) accounted for the largest share of the endoscope reprocessing market.

The Major Players Operating in the Endoscope Reprocessing Market:

The various players in the endoscope reprocessing market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others.

Request Research Sample Pages (Endoscope Reprocessing): https://www.marketsandmarkets.com/requestsampleNew.asp?id=219094994

Objectives of the Study:

• To define, describe, and measure the global endoscope reprocessing market by products, end user, and region
• To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the market
• To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the Global Endoscope Reprocessing Market.
• To analyze the opportunities in the global market for key stakeholders and provide details of the competitive landscape for major market leaders
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)

Geographical Detailed Analysis for Endoscope Reprocessing Market:

North America accounted for the largest share of the endoscope reprocessing market followed by Europe.

In the US, the endoscope reprocessing market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections. In Canada, the growth of the endoscope reprocessing market is driven by the availability of physician bonuses, and implementation of a new funding model for Canadian hospitals.

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more